MEDIGENE AG |
Market Closed -
Other stock markets
|
After market 03:58:01 pm | |||
| 1.295 EUR | -6.83% |
|
1.298 | +0.23% |
| 12:46pm | Medigene, BioNTech Extend Cancer Immunotherapy Partnership | MT |
| May. 15 | Medigene AG Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MEDIGENE AG | Bio Therapeutic Drugs | -6.83% | -13.09% | -15.08% | -20.06% | -84.07% | 37.08M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- MDG1 Stock
- Charts Medigene AG
- Comparison Chart
